299 related articles for article (PubMed ID: 19430766)
1. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Byrne G; Bone KM; Adams J; Deed G
Psychopharmacology (Berl); 2009 Aug; 205(3):399-407. PubMed ID: 19430766
[TBL] [Abstract][Full Text] [Related]
2. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
[TBL] [Abstract][Full Text] [Related]
3. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
[TBL] [Abstract][Full Text] [Related]
4. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
Trials; 2015 Nov; 16():493. PubMed ID: 26527536
[TBL] [Abstract][Full Text] [Related]
5. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
[TBL] [Abstract][Full Text] [Related]
6. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
Pittler MH; Ernst E
J Clin Psychopharmacol; 2000 Feb; 20(1):84-9. PubMed ID: 10653213
[TBL] [Abstract][Full Text] [Related]
8. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
Sarris J; Scholey A; Schweitzer I; Bousman C; Laporte E; Ng C; Murray G; Stough C
Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
[TBL] [Abstract][Full Text] [Related]
9. Kava extract for treating anxiety.
Pittler MH; Ernst E
Cochrane Database Syst Rev; 2003; 2003(1):CD003383. PubMed ID: 12535473
[TBL] [Abstract][Full Text] [Related]
10. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
Thomsen M; Schmidt M
J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
[TBL] [Abstract][Full Text] [Related]
11. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
Sarris J; Kavanagh DJ
J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
[TBL] [Abstract][Full Text] [Related]
12. Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.
Sarris J; Stough C; Teschke R; Wahid ZT; Bousman CA; Murray G; Savage KM; Mouatt P; Ng C; Schweitzer I
Phytother Res; 2013 Nov; 27(11):1723-8. PubMed ID: 23348842
[TBL] [Abstract][Full Text] [Related]
13. Kava extract for treating anxiety.
Pittler MH; Ernst E
Cochrane Database Syst Rev; 2002; (2):CD003383. PubMed ID: 12076477
[TBL] [Abstract][Full Text] [Related]
14. Putative Antidepressant Effect of Chamomile (
Amsterdam JD; Li QS; Xie SX; Mao JJ
J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
[No Abstract] [Full Text] [Related]
15. Kava treatment in patients with anxiety.
Geier FP; Konstantinowicz T
Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
[TBL] [Abstract][Full Text] [Related]
16. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
Sarris J; Kavanagh DJ; Deed G; Bone KM
Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
[TBL] [Abstract][Full Text] [Related]
17. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
Gastpar M; Klimm HD
Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
Malsch U; Kieser M
Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
[TBL] [Abstract][Full Text] [Related]
19. Kava extract for treating anxiety.
Pittler MH; Edzard E
Cochrane Database Syst Rev; 2001; (4):CD003383. PubMed ID: 11687196
[TBL] [Abstract][Full Text] [Related]
20. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia.
Jacobs BP; Bent S; Tice JA; Blackwell T; Cummings SR
Medicine (Baltimore); 2005 Jul; 84(4):197-207. PubMed ID: 16010204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
